Electroconvulsive Therapy
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
General Anesthesia: Overview
Stages of General Anesthesia
Predicting Reaction Outcomes
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 11, 2026

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
Published on: April 11, 2019
Jonathan J Gamble1, Henry Bi2, Rudy Bowen3
1Department of Anesthesia, Perioperative Medicine, and Pain Management, University of Saskatchewan, Royal University Hospital, 103 Hospital Dr, Saskatoon, SK, S7N 0W8, Canada. J_Gamble@yahoo.com.
Ketamine anesthesia for electroconvulsive therapy (ECT) significantly improved outcomes for treatment-resistant major depressive disorder (MDD) compared to propofol. Patients receiving ketamine required fewer ECT sessions for symptom reduction and remission.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: